TRENDING :  Market Movers  |  Top 50   AMD (0%)    NFLX (0%)    SPY (0%)    SPX (0%)    DGAZ (0%)    TSLA (0%)    UGAZ (0%)    VXXB (0%)    VXX (0%)    TWLO (0%)    TLT (0%)    SQQQ (0%)    BOIL (0%)    BABA (0%)    SM (0%)    PCG (0%)    NBEV (0%)    MNGA (0%)    MBOT (0%)    INPX (0%)

 ILMN - Illumina

$313.50 (1.12%)

Next Earnings

1/29/2019

AMC



Analyst Rating

Quarterly Rating Chart
Rating

2


1=Strong Buy, 2=Buy, 3=Hold, 4=Underperform, 5=Sell
Price Targets
High $370.00
Low $288.00
Average $342.67
Current $313.50

CompanyAnalyst NamePT ActionActionRatingTargetDate
Morgan StanleySteve BeuchawLowersMaintainsHold$288.0001/07/19
UBSRaisesUpgradesBuy$370.0001/03/19
BarclaysJack MeehanRaisesMaintainsStrong Buy$370.0010/24/18
*Last 90 days

OPEN RECOMMENDATIONS

No recommendations found.


This list is limited to recommendations made in last 7 days only. Subscribe to a service to see all their recommendations.

TRADERS TRACKING $ILMN

TRENDING ARTICLES



The Zacks Analyst Blog Highlights: Intuitive Surgical, Illumina, HCA, Elanco Animal and Humana

01/16/19
For Immediate Release Chicago IL January 16 2019 Zacks com announces the list of stocks featured in the Analyst Blog Every day the Zacks Equity Research analysts discuss the latest news and events impacting stocks and the financial markets Stocks recently featured in the blog

Notable ETF Outflow Detected - IBB, AMGN, ILMN, REGN

01/16/19
Looking today at week over week shares outstanding changes among the universe of ETFs covered at ETF Channel one standout is the iShares Nasdaq Biotechnology ETF Symbol IBB where we have detected an approximate 202 1 million dollar outflow that s a 2 4 decrease week over week

Why You Should Consider Buying Omnicell (OMCL) Stock Now

01/16/19
Omnicell Inc 160 OMCL has been gaining investor confidence on continued positive results Over the past year the company s share price has outperformed its 160 industry The stock has gained 31 9 against the industry s 13 9 decline and the S amp P 500 s 6 9 fall This

PerkinElmer, Inc. (PKI) Ex-Dividend Date Scheduled for January 17, 2019

01/16/19
PerkinElmer Inc PKI will begin trading ex dividend on January 17 2019 A cash dividend payment of 0 07 per share is scheduled to be paid on February 08 2019 Shareholders who purchased PKI prior to the ex dividend date are eligible for the cash dividend payment This marks the

5 Great Medical Stocks to Buy Ahead of Q4 Earnings

01/15/19
In 2018 health care stocks emerged as some of the best performers for the S amp P 500 which itself closed the year in the red Looking ahead multiple headwinds are clouding the market outlook for the year 2019 These include the ongoing trade war with China the interest rate situation

QIAGEN QFT-Plus Ok'd in Canada, Test Customer Base Expands

01/15/19
QIAGEN N V QGEN recently announced the receipt of Health Canada s 160 approval for QuantiFERON TB Gold Plus QFT Plus as an in vitro diagnostic to detect latent tuberculosis TB infection Built on the QuantiFERON TB Gold QFT platform QFT Plus provides enhanced analysis of TB

Here's Why You Should Invest in Illumina (ILMN) Stock Now

01/14/19
Illumina Inc ILMN has been gaining investor confidence on consistently positive results Over the past year the company s share price has outperformed its 160 industry The stock has gained 25 5 against the industry s 19 7 fall Also the company has outperformed the S amp P 500 s 6

Here's Why Illumina Gained 37.3% in 2018

01/13/19
What happened Shares of Illumina NASDAQ ILMN rose more than 37 last year according to data from S amp P Global Market Intelligence That was easily better than the 6 2 loss on the year for the S amp P 500 but that shouldn t be too surprising The DNA sequencing

Has Illumina (ILMN) Outpaced Other Medical Stocks This Year?

01/11/19
Investors interested in Medical stocks should always be looking to find the best performing companies in the group Has Illumina ILMN been one of those stocks this year A quick glance at the company s year to date performance in comparison to the rest of the Medical sector should help us

Why Investors Didn't Like Illumina's J.P. Morgan Presentation -- but Should Have

01/09/19
It s that time again Healthcare companies and investors flock to San Francisco for the annual J P Morgan Healthcare Conference Sometimes these companies enjoy a nice bump in their stock price as a result of their presentations at the industry s premier conference Not all of them

What Happened in the Stock Market Today

01/09/19
The market put together a third straight day of gains as optimism built that the U S will reach an agreement with China on trade The Dow Jones Industrial Average DJINDICES DJI 160 and the S amp P 500 SNPINDEX GSPC each moved up by about a percentage point Today s

Market Close Report: NASDAQ Composite index closes at 6,897 up 73.53 points

01/08/19
Tuesday s session closes with the NASDAQ Composite Index at 6 897 The total shares traded for the NASDAQ was over 2 3 billion Tuesday s session closes with the NASDAQ Composite Index at 6 897 The total shares traded for the NASDAQ was over 2 3 billion Advancers stocks led declining by 2 15 to

Why Illumina (ILMN) is Poised to Beat Earnings Estimates Again

01/08/19
Looking for a stock that has been consistently beating earnings estimates and might be well positioned to keep the streak alive in its nex t quarterly report Illumina ILMN which belongs to the Zacks Medical Biomedical and Genetics industry could be a great candidate to consider

S&P 500 Movers: PCG, UNP

01/08/19
In early trading on Tuesday shares of Union Pacific Corp UNP topped the list of the day s best performing components of the S amp P 500 index trading up 9 6 Year to date Union Pacific Corp registers a 10 0 gain And the worst performing S amp P 500 component thus far on the day

Nasdaq 100 Movers: ILMN, MNST

01/08/19
In early trading on Tuesday shares of Monster Beverage Corp MNST topped the list of the day s best performing components of the Nasdaq 100 index trading up 5 4 Year to date Monster Beverage Corp registers a 6 5 gain And the worst performing Nasdaq 100 component thus far on the